Your browser doesn't support javascript.
loading
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
Maura, Géric; Blotière, Pierre-Olivier; Bouillon, Kim; Billionnet, Cécile; Ricordeau, Philippe; Alla, François; Zureik, Mahmoud.
Afiliação
  • Maura G; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.). geric.maura@cnamts.
  • Blotière PO; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
  • Bouillon K; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
  • Billionnet C; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
  • Ricordeau P; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
  • Alla F; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
  • Zureik M; From Strategy and Research Department, National Health Insurance (CNAMTS), Paris, France (G.M., P.-O.B., C.B., P.R., F.A.); and Department of Epidemiology of Health Products, French National Agency for Medicines and Health Products Safety (ANSM), Saint-Denis, France (K.B., M.Z.).
Circulation ; 132(13): 1252-60, 2015 Sep 29.
Article em En | MEDLINE | ID: mdl-26199338
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Assunto principal: Arteriopatias Oclusivas / Fibrilação Atrial / Tromboembolia / Vitamina K / Varfarina / Antitrombinas / Trombofilia / Inibidores do Fator Xa / Rivaroxabana / Dabigatrana Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Assunto principal: Arteriopatias Oclusivas / Fibrilação Atrial / Tromboembolia / Vitamina K / Varfarina / Antitrombinas / Trombofilia / Inibidores do Fator Xa / Rivaroxabana / Dabigatrana Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2015 Tipo de documento: Article